Heidelberg Engineering’s SPECTRALIS Technology Spotlighted in Multiple Presentations at ARVO 2019

Participants are invited to attend the Company’s annual Xtreme Research Award Lecture

Vancouver, B.C. – April 26, 2019 – Heidelberg Engineering, a privately-held company providing diagnostic solutions that empower eye care professionals to improve patient care, proudly announced that its multimodal imaging platform, SPECTRALIS, will be strongly represented at the 2019 Association for Research in Vision and Ophthalmology (ARVO) conference, to be held April 28 – May 2 in Vancouver, British Columbia. The SPECTRALIS imaging platform, which offers high-resolution visualization of ocular structures and vasculature, plays an integral role in multiple clinical research studies being presented at ARVO.

Heidelberg Engineering encourages meeting attendees to experience the innovative applications of SPECTRALIS by attending relevant poster and paper presentations (partial list included below). Additionally, Heidelberg Engineering’s 2019 Xtreme Research Award lecture will be held at 7:30 PM Monday, April 29 at Pan Pacific Vancouver, 300-999 Canada Place. The recipients of this year’s award, Lydia Sauer, MD, and Chantal Dysli, MD, PhD, will present their compelling fluorescence lifetime imaging ophthalmoscopy (FLIO) research. To learn more and register, please visit: https://www.heidelbergengineering.com/us/arvo-xtreme/.

“Through our continual technological advancements and longstanding collaborations with innovators in the ophthalmic field, Heidelberg Engineering has exhibited its ongoing commitment to meaningful novelties and quality images. Accordingly, we are proud to play a large role in research being presented at ARVO 2019,” said Mr. Ali Tafreshi, Head of Product Management and Clinical Affairs. “We invite the ophthalmic community to learn more about our latest technology for both the anterior and posterior segments, on-site in Vancouver”.

Recent Innovations to Be Presented at Booth 1117

SPECTRALIS OCT Angiography Module
The OCTA Module for SPECTRALIS delivers high-resolution, non-invasive imaging of ocular vasculature. Combined with the precision of TruTrack Active Eye Tracking, the OCTA Module enables visualization of fine capillary networks in great detail.

SPECTRALIS High Magnification Module (HMM)
This new module, which consists of an innovative lens and software, elegantly demonstrates the capability of confocal scanning laser ophthalmoscopy (cSLO) to resolve ocular microstructures by reducing intraocular light scattering. The detail seen in HMM images may provide novel insights into the pathogenesis and progression of ocular diseases.

Heidelberg Engineering has optimized the longer wavelength and lower sensitivity roll-off of swept-source OCT technology for imaging the anterior segment. ANTERION offers topography, tomography, anterior segment metrics and axial length in one upgradeable, modular device. The stunning swept-source OCT images empower clinicians with visual confirmation of the reliability and accuracy of the measurements.

*ANTERION is not cleared for sale in Canada or the United States.

Paper Presentations Featuring SPECTRALIS*

Wednesday, May 1, 2019

  • 11:15 AM ARVO Ballroom: Optic nerve head (ONH) hypercompliance and blood flow autoregulation dysfunction detected by OCT-angiography (OCTA) in early-state experimental glaucoma (EG)
  • 11:30 AM East 2/3: Reproducibility of retinal erythrocyte velocity using human erythrocyte-mediated angiograms
  • 10:30 AM ARVO Ballroom: Optic nerve head morphological changes over a 12-hour period in a seated vs. head-down tilt posture

Poster Presentations Featuring SPECTRALIS*

Sunday, April 28, 2019

8:00 AM – 9:45 AM

  • 189 – A0598: Optimization and validation of a novel technique for in vivo imaging of FITC-dextran labelled erythrocytes in non-human primates

1:00 PM – 2:45 PM

  • 662 – B0140: Extracellular Matrix Tissue content of the neuroretinal rim differs in healthy and glaucomatous eyes

Monday, April 29, 2019

8:15 AM – 10:00 AM

  • 1496 – A0180: Automatic segmentation of retinal capillaries in adaptive optics perfusion images using a convolutional neural network

Tuesday, April 30, 2019

8:45 AM – 10:30 AM

  • 2976 – A0259: Monocyte-related biomarkers of intermediate age-related macular degeneration
  • 3091 – A0434: Factors Affecting the variability of vessel width measurements within individual vessels in OCT angiography
  • 3087 – A0430: Variability and repeatability of retinal vessel caliber measurements with optical coherence tomography angiography

11:45 AM – 1:30 PM

  • 3619 – B0033: Correlation of novel macular structural and vascular abnormalities in familial exudative vitreoretinopathy

Wednesday, May 1, 2019

3:00 PM – 4:45 PM

  • 5596 – B0487: Optic nerve head prelaminar tissue schisis: a sign of glaucomatous deformation?

Thursday, May 2, 2019

8:00 AM – 9:45 AM

  • 5738 – A0133: Determination of absolute diastolic erythrocyte velocities in peripapillary arterioles and venuoles of human subjects using erythrocyte mediated angiography

Please visit us during ARVO at booth #1117.

*This is a partial list of abstracts that include SPECTRALIS.

back to overview